This content is machine translated Medicalonline Long-term data on upadacitinib show a consistent safety profile and no new safety signals [1]. * With the exception of the already known higher herpes zoster and NMSC events and higher CPK levels.
View Post 9 min This content is machine translated Sponsored Content: PARKINSON DISEASE (PD) Tailored therapy for motor fluctuations At the EAN Congress 2022, a Bial satellite symposium discussed treatment options for motor fluctuations and presented new data on the pharmacokinetics of levodopa in combination with the COMT inhibitor…
View Post 6 min This content is machine translated Locally advanced or metastatic urothelial carcinoma Subgroup analyses of the JAVELIN Bladder 100 study – In the context of clinical practice. First-line chemotherapy followed by avelumab (BAVENCIO®)-maintenance therapy is the standard of care for patients with locally advanced or metastatic urothelial carcinoma who have not progressed on platinum-based chemotherapy, according to…
View Post 1 min This content is machine translated Swiss Oncology in Motion Module Urothelial Carcinoma Oncology is constantly changing, with additional diagnostic procedures, new surgical methods and innovative therapeutic concepts being developed. For this reason, the treatment guidelines are also continuously revised. This also applies… CME-Test
View Post 5 min This content is machine translated Interview with Natalie Marcoli, MD “Personalized treatment in rheumatology would help even more patients achieve remission.” Achieving remission is the ultimate goal in the treatment of the inflammatory rheumatic diseases rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis [1-3]. In the following interview, Natalie Marcoli, MD, from…
View Post 8 min This content is machine translated Inflammatory rheumatic diseases Current data and expert opinions on the therapeutic goal of remission The management of inflammatory rheumatic diseases has improved significantly in recent years with the development of targeted treatments [1]. But how realistic is achieving remission today? The following report provides…
View Post 6 min This content is machine translated Type 2 diabetes: new ADA/EASD consensus report. Holistic treatment with a view to cardiorenal effects. The 2022 position paper of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) proposes to implement a holistic, multimodal treatment approach in the…
View Post 4 min This content is machine translated Therapy of type 2 diabetes in older age Avoid hypoglycemia and consider multimorbidity Over the past three decades, global diabetes prevalence has steadily increased, with an age-correlated increase in prevalence. Therapeutic goals in older type 2 diabetic patients differ from those of younger…
View Post 3 min This content is machine translated Diabetes Keeping an eye on weight: New insights in therapy management The global diabetes community met in Stockholm to benefit from the latest research and innovations in the field of diabetes. At the 58th Annual Meeting of the European Association for…
View Post 3 min This content is machine translated Diabetes mellitus type 1 Are there signs of autoimmune polyendocrine syndrome? Patients with type 1 diabetes have a higher risk of developing other autoimmune diseases. The autoimmune-related polyendocrine syndromes are rare but should be detected in time. Certain genetic mutations are…
View Post 9 min This content is machine translated Interview with Prof. Dr. med. Gerd Burmester “With the JAK inhibitors, we can get much more out of them for our patients” Oral Janus kinase inhibitors (JAKi) have been expanding the treatment landscape for inflammatory rheumatoid diseases for several years. In the following interview, Prof. Dr. med. Gerd Burmester explains what this…
